Tibud, Lolly S.
HRN: 06-47-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2024
CEFTRIAXONE 1G (VIAL)
03/06/2024
03/15/2024
IV
2g
Q24h
COVID19 Pneumonia
Waiting Final Action